Evaluation of mathematical models for predicting medicine distribution into breastmilk - considering biological heterogeneity
Frontiers in Pharmacology · 29.11.2024 · 15
DOI: 10.3389/fphar.2024.1507551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.11.2024. Verfasst von Sumin Heo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicines and Healthcare products Regulatory Agency (MHRA), London, United Kingdom. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Introduction
A significant proportion of mothers take medication during the breastfeeding period, however knowledge of infant safety during continued breastfeeding is often limited. Breastmilk exhibits significant physiological heterogeneity, with a range of milk fat (creamatocrit), protein and pH values available within the literature. Mathematical models for the prediction of infant exposure are available and these predict that variable milk physiology will significantly affect accumulation of drugs within the breastmilk. These models are typically validated against limited datasets only, and to the best of our knowledge no widescale review has been conducted which accounts for the heterogeneity of breastmilk.
Methods
Observed area under the curve milk-to-plasma (M/P) ratios and physicochemical properties were collected for a diverse range of drugs. The reliability of previously published mathematical models was assessed by varying milk pH and creamatocrit across the physiological range. Subsequently, alternative methods for predicting lipid and protein binding within the milk, and the effect of ionisation and physicochemical properties were investigated.
Results
Existing models mis-predicted >40% of medications (Phase Distribution model), exhibited extreme sensitivity to milk pH (Log-Transformed model) or exhibited limited sensitivity to changes in creamatocrit (LogP o:w model). Alternative methods of predicting distribution into milk lipids moderately improved predictions, however altering the way in which milk protein binding was predicted and the effect of ionisation on this demonstrated little effect. Many drugs were predicted to have a significant range of M/P ratios.
Discussion
These data show that consideration of the biological heterogeneity of breastmilk is important for model development and highlight that increased understanding of the physiological mechanisms underlying distribution within the milk may be essential to continue improving in silico methodologies to support infant and maternal health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicines and Healthcare products Regulatory Agency (MHRA), London, United Kingdom.
- Department of Analytical, Environmental and Forensic Sciences, King's College London, London, United Kingdom.
Förderung
- Gates Foundation
- Bill and Melinda Gates Foundation
Zitieren
APA
Heo, S., Butler, A. S., Stamouli Simoncioni, M., Moult, S., Malamatari, M., Kerwash, E., & Cole, S. (2024). Evaluation of mathematical models for predicting medicine distribution into breastmilk - considering biological heterogeneity. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1507551
Vancouver
Heo S, Butler AS, Stamouli Simoncioni M, Moult S, Malamatari M, Kerwash E, et al. Evaluation of mathematical models for predicting medicine distribution into breastmilk - considering biological heterogeneity. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1507551
BibTeX
@article{Heo2024,
author = {Heo, Sumin and Butler, Andrew S and Stamouli Simoncioni, Marina and Moult, Sam and Malamatari, Maria and Kerwash, Essam and Cole, Susan},
title = {Evaluation of mathematical models for predicting medicine distribution into breastmilk - considering biological heterogeneity},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1507551}
}
EUVIMED